Organigram Global Inc. (OGI) Q3 2025 Earnings Call Transcript — Neutral
OGI Seeking Alpha — August 13, 2025Title: Organigram Global Inc. (NASDAQ:OGI ) Q3 2025 Earnings Call August 13, 2025 8:00 AM ET Company Participants Beena G. Goldenberg - CEO & Director Greg Guyatt - Chief Financial Officer Max Schwartz - Director of Investor Relations Conference Call Participants Aaron Thomas Grey - Alliance Global Partners, Research Division Frederico Yokota Choucair Gomes - ATB Capital Markets Inc., Research Division Operator Good morning.
Rocket Lab Scores Analyst Upgrades, Finalizes Geost Takeover — Positive
RKLB MarketBeat — August 13, 2025Rocket Lab USA NASDAQ: RKLB is enjoying a surge of positive sentiment and continued momentum as it further captures Wall Street's attention and strengthens its position in the national security space sector.
Celsius (CELH) Chariman & CEO on Strong Earnings, Alani Nu & Energy "Movement" — Positive
CELH Schwab Network — August 13, 2025John Fieldly, Chairman and CEO of Celsius (CELH), talks about the company's recent earnings led by a sales surge following its acquisition of Alani Nu. He notes that female and Gen Z customers are the ones leading the company's growth though a new "movement" in the energy drink space.
The Marzetti Company Continues Higher Cash Dividend; Board of Directors Sets Annual Meeting Date and Time — Neutral
MZTI Business Wire — August 13, 2025WESTERVILLE, Ohio--(BUSINESS WIRE)--The Marzetti Company (Nasdaq: MZTI) announced today that its Board of Directors has declared a quarterly cash dividend of 95 cents per common share, payable September 30, 2025 to shareholders of record on September 8, 2025. The quarterly cash dividend amount of 95 cents per share maintains the higher level set nine months ago, which marked the company's 62nd consecutive year of increased regular cash dividends. The Marzetti Company is one of only 12 U.S. comp.
Initiative to expand testing access to underserved U.S. communities SAN DIEGO , Aug. 13, 2025 /PRNewswire/ -- QuidelOrtho Corporation has launched a Certified Analyzer Program, an innovative initiative designed to expand access to high-quality diagnostic testing in rural and community hospitals across the United States. Tailored for clinics, physician office labs and small hospitals with fewer than 100 beds, the program offers certified VITROS™ analyzers that deliver proven reliability and quality results, with award-winning service, at a fraction of the cost.
These Analysts Slash Their Forecasts On Altimmune Following Q2 Results — Negative
ALT Benzinga — August 13, 2025Altimmune, Inc. ALT posted a loss for the second quarter on Tuesday.
Endeavour Silver Corp. (EXK) Q2 2025 Earnings Call Transcript — Neutral
EDR EXK Seeking Alpha — August 13, 2025Endeavour Silver Corp. (NYSE:EXK ) Q2 2025 Earnings Conference Call August 13, 2025 1:00 PM ET Company Participants Allison Lauren Pettit - Director of Investor Relations Daniel W. Dickson - CEO & Director Donald P.
Gambling.com is misunderstood, with AI fears and market misconceptions driving shares to deeply undervalued levels despite strong fundamentals and a business model shift. Shares are worth more than $30 each. The company's pivot to data-driven, subscription-based revenue via Odds Holdings now provides over 50% recurring revenue, creating a more durable and valuable business. Management is highly aligned with shareholders through significant insider ownership, buybacks, and incentive structures tied to aggressive market cap milestones.
Comstock Q2 Earnings Surge Y/Y on Recurring Fee Growth — Positive
CHCI Zacks Investment Research — August 13, 2025CHCI's Q2 EPS improve 56% year over year, while revenues rose 21%, fueled by strong recurring fees, leasing momentum, and progress on its Reston Station development.
Cava, Chipotle and other fast-casual restaurant chains are finally hit by consumer slowdown — Negative
CAVA CMG CNBC — August 13, 2025After bucking industry trends, fast-casual chains like Chipotle and Cava are finally feeling the consumer slowdown. Restaurant executives have said that diners are "cautious" or dealing with an economic "fog.
Three Stocks Morgan Stanley Recommends for Playing the ‘Nuclear Renaissance' — Positive
PEG TLN VST Investopedia — August 13, 2025The world is having a “nuclear renaissance,” according to Morgan Stanley, and the opportunity for investors is ample.
GII is a buy for exposure to global infrastructure, benefiting from AI, renewables, and urbanization megatrends driving robust long-term demand. The ETF offers a high dividend yield, resilient industry exposure, and global diversification, positioning it well for future growth. While GII outperforms its peers despite a slightly higher expense ratio and lower liquidity, its concentration and trading volume present moderate risks.
Catalysts Align: Archer Beats Estimates, Delivers Aircraft to UAE — Positive
ACHR MarketBeat — August 13, 2025Archer Aviation's NYSE: ACHR second-quarter 2025 results have provided investors with the clearest signals yet of its transition from a developmental concept to a commercial reality.
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Altimmune, Inc. (ALT) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm — Neutral
ALT GlobeNewsWire — August 13, 2025ATLANTA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed Altimmune, Inc. (“Altimmune” or the “Company”) (NASDAQ: ALT). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information, including allegations that the Company consistently touted its inflated expectations for positive topline results from the IMPACT Phase 2b MASH trial, while concealing higher responses in the placebo group, which they knew or should have known would negatively impact the topline results.
Evotec SE (NASDAQ:EVO ) Q2 2025 Earnings Conference Call August 13, 2025 8:00 AM ET Company Participants Christian Wojczewski - CEO & Management Board Member Cord Dohrmann - Chief Scientific Officer & Member of Management Board Paul Hitchin - CFO & Member of Management Board Volker Braun - Executive VP and Head of Global Investor Relations & ESG Conference Call Participants Brendan Mychal Smith - TD Cowen, Research Division Charles Robert Weston - RBC Capital Markets, Research Division Christian Ehmann - Warburg Research GmbH Douglas Dylan Tsao - H.C. Wainwright & Co, LLC, Research Division Fynn Scherzler - Deutsche Bank …
We focus on identifying futuristic industries poised to outperform, with flying electric vehicles as a prime example. Joby Aviation and Archer Aviation are top contenders in this emerging sector, each with strong growth and earnings potential. I analyze both companies to determine which is better positioned for future dominance and potential monopoly/duopoly status.
Smithfield Foods Analysts Boost Their Forecasts After Q2 Results — Positive
SFD Benzinga — August 13, 2025Smithfield Foods, Inc. SFD reported in-line earnings for the second quarter on Tuesday.
China Automotive Systems, Inc. (CAAS) Q2 2025 Earnings Call Transcript — Neutral
CAAS Seeking Alpha — August 13, 2025China Automotive Systems, Inc. (NASDAQ:CAAS ) Q2 2025 Earnings Conference Call August 13, 2025 8:00 AM ET Company Participants Jie Li - Chief Financial Officer Kevin Theiss - Manager of Investor Relations Conference Call Participants Gary Nash - Unidentified Company SHAREHOLDERS - Unidentified Company Unknown Shareholder - Unidentified Company Kevin Theiss Thank you, everyone, for joining us today. Welcome to China Automotive Systems 2025 second quarter conference call.
Bullish IPO is the final ingredient to make a market bubble, says MAI's Chris Grisanti — Negative
BLSH CNBC Television — August 13, 2025Chris Grisanti, MAI Capital Management chief market strategist, joins 'Power Lunch' to discuss the two conflicting market narratives, how much stock buybacks are propelling this equity market and much more.